Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer
Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. It is not yet known which chemotherapy regimen is more effective
for liver cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of two different
chemotherapy regimens in treating patients who have recurrent or unresectable liver cancer.